80890-46-6

Hylambatin, a tachykinin, increases both plasma glucose and plasma insulin, whereas the secretion of glucagon was not affected. Hylambatin can be used in diabetes research[1].

Tachykinin th at increases plasma glucose and plasma insulin.

[1] Güllner HG, et al. Hylambatin, a structurally unique tachykinin: effects on insulin and glucagon secretion. Arch Int Pharmacodyn Ther. 1984 Dec;272(2):304-9. PMID:6395822